Genmab Ownership | Who Owns Genmab?
Genmab Ownership Summary
Genmab is owned by 1.36% institutional investors, and 98.64% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of GMAB shares. AllianceBernstein US L/C Growth Eqty MF is the top mutual fund, with 0.64% of its assets in Genmab shares.
GMAB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Genmab | 1.36% | - | 98.64% |
| Sector | Healthcare Stocks | 35.34% | 11.88% | 52.77% |
| Industry | Biotech Stocks | 35.37% | 11.83% | 52.80% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 5.08M | 7.78% | $127.67M |
| Orbis allan gray | 12.93M | 2.10% | $346.79M |
| Bank of america corp /de/ | 1.10M | 1.68% | $27.57M |
| Alliancebernstein | 9.56M | 1.55% | $294.36M |
| Paradigm biocapital advisors lp | 7.97M | 1.29% | $213.78M |
| Arrowstreet capital, limited partnership | 4.98M | 0.81% | $133.49M |
| Blackrock funding, inc. /de | 4.54M | 0.74% | $121.72M |
| Renaissance | 4.41M | 0.72% | $118.44M |
| Deep track capital, lp | 3.66M | 0.59% | $98.28M |
| Harding loevner lp | 3.23M | 0.52% | $86.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ikarian capital | 175.00K | 5.35% | $53.02M |
| Paradigm biocapital advisors lp | 7.97M | 4.37% | $213.78M |
| Superstring capital management lp | 196.71K | 3.77% | $5.28M |
| Deep track capital, lp | 3.66M | 1.60% | $98.28M |
| Orbis allan gray | 12.93M | 1.46% | $346.79M |
| Aimz investment advisors | 160.91K | 1.33% | $4.32M |
| Harding loevner lp | 3.23M | 0.89% | $86.70M |
| Terra nova asset management | 42.64K | 0.85% | $1.14M |
| Deerfield management company, l.p. (series c) | 2.46M | 0.78% | $66.06M |
| Sofinnova investments | 752.26K | 0.77% | $20.18M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 3.66M | 1.60% | 3.66M |
| Deerfield management company, l.p. (series c) | 2.46M | 0.78% | 2.46M |
| Two sigma investments, lp | 2.34M | 0.05% | 1.44M |
| Franklin resources | 1.19M | 0.01% | 1.16M |
| First trust advisors lp | 2.46M | 0.05% | 1.13M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -2.57M |
| Wellington management group llp | - | - | -2.31M |
| Orbis allan gray | 12.93M | 1.46% | -1.49M |
| Alliancebernstein | 9.56M | 0.10% | -1.32M |
| Ddd partners | - | - | -601.05K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deerfield management company, l.p. (series c) | 2.46M | 0.78% | 2.46M | $66.06M |
| Sofinnova investments | 752.26K | 0.77% | 752.26K | $20.18M |
| Moore capital management, lp | 211.71K | 0.12% | 211.71K | $5.68M |
| Toroso investments | 184.12K | 0.01% | 184.12K | $4.94M |
| Ikarian capital | 175.00K | 5.35% | 175.00K | $53.02M |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -1.00 |
| Deutsche bank ag\ | -4.00 |
| Bear mountain capital | -6.00 |
| Mendota financial group | -8.00 |
| American capital advisory | -8.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 146 | -50.34% | 8,396,925 | -88.53% | 1 | 0.96% | 74 | -63.00% | 48 | -5.88% |
| Dec 31, 2025 | 222 | -12.60% | 29,400,140 | -52.44% | 4 | 4.76% | 148 | -10.84% | 38 | -37.70% |
| Sep 30, 2025 | 179 | -15.96% | 28,573,191 | -37.70% | 4 | 0.09% | 120 | 5.26% | 40 | -44.44% |
| Jun 30, 2025 | 219 | -3.52% | 63,692,065 | -1.88% | 99 | 0.96% | 116 | -11.45% | 74 | 12.12% |
| Mar 31, 2025 | 226 | -2.59% | 64,889,241 | 6.75% | 101 | 1.16% | 129 | 3.20% | 67 | -10.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| AllianceBernstein US L/C Growth Eqty MF | 3.95M | 0.64% | - |
| iShares Biotechnology ETF | 3.54M | 0.58% | 49.48K |
| Orbis SICAV Intl Eq Inv | 3.09M | 0.50% | -306.17K |
| First Trust NYSE Arca Biotech ETF | 2.66M | 0.43% | -12.42K |
| Vanguard Health Care Inv | 2.29M | 0.36% | - |
| AB Large Cap Growth A | 1.85M | 0.30% | -172.84K |
| T. Rowe Price International Gr Eq SMA | 1.90M | 0.30% | 1.90M |
| Orbis SICAV Global Bal Instl Inv | 1.41M | 0.23% | 528.30K |
| Orbis Global Equity Investor | 1.31M | 0.21% | - |
| AB US Large Cap Growth CT B | 995.12K | 0.16% | -12.60K |
GMAB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools